文献速递临床生化质量管理与危急值

基于核磁共振代谢组学方法评估39种血清代谢物的短期与长期生物学变异

Assessment of short- and long-term biological variation for 39 serum metabolites using an NMR-based metabolomics approach.
PubMed 文献 · Clin Chem Lab Med · 2026-10-21

结果显示NMR与酶法肌酐生物学变异一致,周与月变异相似,部分代谢物分析不精密度超过APS,6种个体指数<0.6。

要点

  • NMR法肌酐生物学变异与酶法结果一致,支持方法间可比性。
  • 周与月CVI和CVG相似,提示代谢物变异性在观察期内相对稳定。
  • 6种代谢物个体指数<0.6,提示这些项目参考区间对个体解释价值有限。

核心结论

  • 本研究提供了NMR法检测39种血清代谢物的短期与长期生物学变异估计,可作为解读代谢组学检测的框架。
  • 这些数据在临床应用前仍需独立的分析与临床验证。

研究设计与样本

  • 每周采样持续10周、每月采样持续10个月,用NMR定量39种代谢物,肌酐同时用酶法测定。
  • 分析变异由混合样本计算,经CV-ANOVA确定带置信区间的生物学变异估计、个体指数、参考变化值、估计个体稳态设定点所需标本数和APS。

主要发现

  • NMR法肌酐的生物学变异组分与酶法结果一致。
  • 与EFLM生物学变异荟萃分析相比,抗坏血酸、肌酐和葡萄糖高度一致,尿素CVI较高。
  • 周与月CVI和CVG相似,提示代谢变异性随时间稳定。
  • 性别分层分析显示部分代谢物CVI存在差异,但多数置信区间重叠。
  • 8种代谢物分析不精密度超过APS,6种代谢物个体指数<0.6,参考变化值在不同代谢物间差异较大。

关键数值与推荐

  • 研究给出39种NMR定量血清代谢物的短期与长期CVI和CVG、个体指数、参考变化值及APS。
  • 8种代谢物分析不精密度超过APS。
  • 6种代谢物个体指数<0.6。
  • 参考变化值在不同代谢物间差异较大。

临床怎么用

  • 可将本研究的生物学变异数据作为NMR代谢组学检测结果解读的参考框架。
  • 对个体指数<0.6的代谢物,解读个体结果时应关注参考变化值而非群体参考区间。
  • 临床应用前需在本实验室完成独立分析验证与临床验证。

局限性

  • 生物学变异估计为方法依赖性,推广至其他NMR平台或检测流程需验证。
  • 研究数据尚需独立分析与临床验证后方可用于临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: As personalized medicine expands, metabolomics may support clinical decision-making. However, its integration in routine requires biological variation (BV) data, which remain scarce. Here, we aimed to generate short- and long-term CVI and CVG components, index of individuality (II), reference change values (RCV) and analytical performance specifications (APS) for serum metabolites quantified by NMR spectroscopy. METHODS: Thirty healthy individuals (14 males, 16 females; age 23-40 years) provided serum weekly for 10 weeks and monthly for 10 months, following European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Biological Variation recommendations. Thirty-nine metabolites were quantified by NMR, while creatinine was also measured enzymatically. Analytical variation (CVA) was calculated from pooled samples. Outliers and trends were evaluated before CV-ANOVA to determine BV estimates with confidence intervals (CIs), II, RCVs, number of specimens estimating the individual's homeostatic set point, and APS. RESULTS: NMR-based creatinine BV components aligned with enzymatic results. Comparison with EFLM BV meta-analysis agreed strongly for ascorbate, creatinine, and glucose, while urea exhibited higher CVI. Weekly and monthly CVI and CVG were similar, indicating stable metabolic variability over time. Sex-stratified analyses showed CVI differences for some metabolites, but most CIs overlapped. Eight metabolites exceeded APS for imprecision, six showed II <0.6, and RCVs varied widely across metabolites. CONCLUSIONS: This study provides method-dependent short- and long-term BV estimates for 39 serum metabolites measured by NMR. These data provide a framework for interpreting metabolomic measurements based on BV but require independent analytical and clinical validation before clinical application.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Campas M, Le Goff C, de Tullio P, et al. Assessment of short- and long-term biological variation for 39 serum metabolites using an NMR-based metabolomics approach. Clin Chem Lab Med. 2026. PMID: 42905573. doi:10.1515/cclm-2026-1138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。